TheraNews
Subscribe

Archive summary Policy & payers

Mochi Health weight loss review: 2026 plans and effectiveness

Mochi Health offers virtual weight loss support but experts warn about compounded meds and lab requirements.

Summary of reporting by usatoday 2 min read Markdown

Mochi Health is a subscription-based telehealth platform founded in 2022 that connects patients virtually with board-certified doctors and registered dietitians for physician-guided weight loss using GLP-1 medications. According to Mochi Health, more than half of its patients lose at least 10% of body weight within the first six months, with an average weight loss of 16% in the first year. However, medication alone is not the complete solution—comprehensive obesity care requires nutrition, movement, behavior change and medication or procedural interventions working together.

The standard Mochi Health subscription starts at $79 per month, with longer commitments bringing lower costs: 3 months for $199, 6 months for $399, and 12 months for $799. Patients with qualifying insurance can access the Wellness Plus Plan at lower rates: $69, $169, $299 or $589 for the same terms. Medication is billed separately, with compounded semaglutide starting at $99 per month and compounded tirzepatide at $199 per month, regardless of dose. All Mochi plans include 24/7 patient support, direct provider messaging and an online portal for booking visits, managing prescriptions and tracking progress.

Strengths and Concerns

Mochi has a 4.4 rating out of 5 on Trustpilot based on over 16,000 reviews, with multiple reviewers praising physician guidance, nutritionist support and affordability. The Better Business Bureau gave Mochi Health a B- rating based on complaint patterns and response times. However, some patient reviews mention difficulty reaching providers and unexpected charges after cancellation.

A significant drawback is that while Mochi offers FDA-approved brand-name GLP-1s like Wegovy, it also provides compounded medications, which are not FDA approved. Compounded medications raise questions, as prescribers profit from dispensing them. Additionally, Mochi does not require labs for all patients before starting treatment, though quality telehealth programs should require baseline thyroid function, metabolic panel, kidney and liver markers before initiation.


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.usatoday.com/story/life/health-wellness/2026/06/02/mochi-weight-loss-review/90375756007/

Original report

Mochi Health weight loss review: 2026 plans and effectiveness
usatoday

About this article

  • Educational, not advice. Nothing here is medical, legal, billing or financial advice. Clinical decisions belong with a licensed clinician; coverage and legal questions belong with the payer, the statute or counsel. Prices and rates change; confirm them with the provider and the plan.
  • Corrections. If something on this page is wrong, send a correction with the source.

Topics: health-equity

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.